Atrial Fibrillation Trial, Recruiting NCT06392932 Sponsor: Cedars-Sinai Medical Center Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT06392932
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are able to sign and date a consent form agreeing to take part in the study
  • People who are willing to follow all study procedures and are available for the full duration of the study
  • People who are 18 years of age or older, of any gender
  • People who have been diagnosed with paroxysmal atrial fibrillation (a type of irregular heartbeat that comes and goes)
  • People who are scheduled to have a specific type of heart procedure called radiofrequency catheter ablation to treat their atrial fibrillation, where the treatment targets the pulmonary veins only, with no additional treatment planned for another area of the heart called the left atrial posterior wall

Who may not be able to join:

  • People who have previously had an ablation procedure on the left side of their heart
  • People for whom the use of a specific ablation device (the Q-DOT Micro catheter in a particular high-power setting) is considered unsafe by their treating doctor
  • People who have medical reasons why they cannot undergo capsule endoscopy (a procedure involving swallowing a small camera), or who have digestive conditions that may make that procedure riskier, such as a narrowed oesophagus or inflammatory bowel disease
  • People whose medical records include a "break the glass" flag or a "research opt out" notation (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 310-248-6679

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Cedars-Sinai Medical Center
Registry
ClinicalTrials.gov
Start date
4 October 2024
Est. completion
1 October 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Maximal change in esophageal temperature during posterior wall isolation.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov